Literature DB >> 17974697

B-type natriuretic peptide and left ventricular dysfunction on exercise echocardiography in patients with chronic aortic regurgitation.

R S Gabriel1, A J Kerr, V Sharma, I S L Zeng, R A H Stewart.   

Abstract

OBJECTIVE: To determine whether plasma levels of B-type natriuretic peptide (BNP) predict left ventricular (LV) dysfunction on exercise echocardiography in patients with moderate to severe aortic regurgitation (AR).
DESIGN: Case-control study.
SETTING: Outpatient cardiology departments. PATIENTS: 39 asymptomatic or mildly symptomatic patients with chronic moderate to severe AR and a normal LV ejection fraction (>50%), and 10 normal controls. MAIN OUTCOME MEASURES: Plasma level of BNP and echocardiographic measures of LV function at rest and immediately after treadmill exercise.
RESULTS: LV end systolic volume index (LVESVI) was significantly increased in AR patients with normal BNP (<or=12 pmol/l) compared with controls (mean (SD) 32 (13) vs 17 (7) ml/m(2), p = 0.002) but was similar for AR patients with normal and elevated BNP (38 (16), p = 0.14). In AR patients there was no association between plasma BNP and measures of LV function on echocardiography at rest (r<0.30, p>0.05 for all). However, there were modest but statistically significant associations between the plasma level of BNP and severity of AR indicated by a greater AR:LV outflow tract width ratio (r = 0.37, p = 0.02) and lower diastolic blood pressure (r = -0.44, p = 0.004). Increased BNP was also associated with a greater LVESVI (r = 0.33, p = 0.04) and lower LV longitudinal strain rate (r = -0.037, 0.02) on echocardiography after exercise.
CONCLUSIONS: In moderate to severe AR compensatory LV remodelling can occur with no increase in plasma BNP. Increased BNP is associated with more severe regurgitation and changes consistent with early LV dysfunction on exercise echocardiography.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17974697     DOI: 10.1136/hrt.2007.126508

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  11 in total

Review 1.  Contemporary reviews by surgeon: timing of operation for chronic aortic regurgitation.

Authors:  Kazuhiro Taniguchi; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-09-26

2.  Left ventricular shape and mass impact torsional dynamics in asymptomatic patients with chronic aortic regurgitation and normal left ventricular ejection fraction.

Authors:  Roxana Enache; Bogdan A Popescu; Rita Piazza; Denisa Muraru; Andreea Călin; Carmen C Beladan; Monica Roşca; Gian Luigi Nicolosi; Carmen Ginghină
Journal:  Int J Cardiovasc Imaging       Date:  2015-05-21       Impact factor: 2.357

Review 3.  Current Management of Patients with Severe Aortic Regurgitation.

Authors:  Charles Nadeau-Routhier; Ons Marsit; Jonathan Beaudoin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

Review 4.  Natriuretic peptides in the management of aortic stenosis.

Authors:  Jutta Bergler-Klein
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

5.  Comparison of effects of losartan and metoprolol on left ventricular and aortic function at rest and during exercise in chronic aortic regurgitation.

Authors:  Paul A Roberts; Aaron C W Lin; Brett R Cowan; Alistair A Young; Ralph Stewart
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-08       Impact factor: 2.357

6.  Right ventricular dysfunction and B-type natriuretic peptide in asymptomatic patients after repair for tetralogy of Fallot.

Authors:  Christian Apitz; Ludger Sieverding; Heiner Latus; Anselm Uebing; Stefan Schoof; Michael Hofbeck
Journal:  Pediatr Cardiol       Date:  2009-05-28       Impact factor: 1.655

7.  Plasma brain natriuretic peptide concentrations in patients with valvular heart disease.

Authors:  Vishal Sharma; Ralph A Stewart; Mildred Lee; Ruvin Gabriel; Niels Van Pelt; David E Newby; Andrew J Kerr
Journal:  Open Heart       Date:  2016-05-04

8.  Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach.

Authors:  Svetlana Becker; Anca Florian; Alexandru Patrascu; Sabine Rösch; Johannes Waltenberger; Udo Sechtem; Matthias Schwab; Elke Schaeffeler; Ali Yilmaz
Journal:  J Cardiovasc Magn Reson       Date:  2016-05-06       Impact factor: 5.364

9.  Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach.

Authors:  Ali Yilmaz; Hans-Jürgen Gdynia; Hannibal Baccouche; Heiko Mahrholdt; Gabriel Meinhardt; Cristina Basso; Gaetano Thiene; Anne-Dorte Sperfeld; Albert C Ludolph; Udo Sechtem
Journal:  J Cardiovasc Magn Reson       Date:  2008-11-04       Impact factor: 5.364

10.  Exercise stress echocardiography in patients with valvular heart disease.

Authors:  Vishal Sharma; David E Newby; Ralph A H Stewart; Mildred Lee; Ruvin Gabriel; Niels Van Pelt; Andrew J Kerr
Journal:  Echo Res Pract       Date:  2015-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.